These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 35137195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phosphate homeostasis in Bartter syndrome: a case-control study.
    Bettinelli A, Viganò C, Provero MC, Barretta F, Albisetti A, Tedeschi S, Scicchitano B, Bianchetti MG.
    Pediatr Nephrol; 2014 Nov; 29(11):2133-8. PubMed ID: 24902942
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome.
    Tang W, Chai Y, Jia H, Wang B, Liu T, Wang H, Dai C.
    BMC Endocr Disord; 2022 Feb 11; 22(1):38. PubMed ID: 35148746
    [Abstract] [Full Text] [Related]

  • 7. Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes.
    Corbetta S, Raimondo F, Tedeschi S, Syrèn ML, Rebora P, Savoia A, Baldi L, Bettinelli A, Pitto M.
    Nephrol Dial Transplant; 2015 Apr 11; 30(4):621-30. PubMed ID: 25422309
    [Abstract] [Full Text] [Related]

  • 8. Renal phosphate handling in Gitelman syndrome--the results of a case-control study.
    Viganò C, Amoruso C, Barretta F, Minnici G, Albisetti W, Syrèn ML, Bianchetti MG, Bettinelli A.
    Pediatr Nephrol; 2013 Jan 11; 28(1):65-70. PubMed ID: 22990302
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U, Chan JC.
    J Clin Endocrinol Metab; 1984 Apr 11; 58(4):671-5. PubMed ID: 6546575
    [Abstract] [Full Text] [Related]

  • 13. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure.
    Parfitt AM, Kleerekoper M, Cruz C.
    Miner Electrolyte Metab; 1986 Apr 11; 12(5-6):356-62. PubMed ID: 3543637
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
    Phelps KR, Mason DL.
    Am J Nephrol; 2018 Apr 11; 47(5):343-351. PubMed ID: 29779023
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
    Evenepoel P, Meijers B, Viaene L, Bammens B, Claes K, Kuypers D, Vanderschueren D, Vanrenterghem Y.
    Clin J Am Soc Nephrol; 2010 Jul 11; 5(7):1268-76. PubMed ID: 20448073
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Calcium clamp technique: suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism.
    Sørensen HA, Schwarz P, McNair P, Hyldstrup L, Transbøl I.
    Scand J Clin Lab Invest; 1992 Oct 11; 52(6):457-65. PubMed ID: 1411258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.